Institutional investors purchased a net $229.9 thousand shares of BIOC during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 4.80% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 116.3 Thousand shares of Biocept Inc
FRIGATE VENTURES LP Bought 111.0 Thousand shares of Biocept Inc
THE VANGUARD GROUP, INC. Bought 29.9 Thousand shares of Biocept Inc